Seeger Weiss LLP Commences Personal Injury and Consumer Class Actions Following Recall of Hydroxycut Products
New York, New York—May 4, 2009
Seeger Weiss LLP announced that it will be commencing personal injury actions and consumer fraud claims on behalf of those victims who suffered personal injury and/or economic losses resulting from their purchase and ingestion of the dietary supplement, Hydroxycut.
On May 1, 2009, the FDA announced a recall of 14 different Hydroxycut products, following at least 23 reports of liver problems, including one death of a 19-year-old boy. This death occurred in 2007 but does not appear to have been reported to the Agency until last month. At least one patient has required a liver transplant. The FDA warned dieters and body builders to immediately cease use of the weight loss products. Symptoms of liver damage include jaundice, a yellowing of the skin or eyes, brown urine, nausea, vomiting, excessive fatigue, weakness, stomach pain, itching and loss of appetite. Other health problems have also been reported, including: seizures, cardiovascular disorders and rhabdomyolysis, a form of muscle damage that can cause kidney failure.
Hydroxycut is manufactured by Iovate Health Sciences, Inc. and distributed under the Iovate and Muscletech brand names. Hydroxycut is estimated to account for nearly 90 percent of the market for weight loss supplements and sold a reported nine million packages last year through pharmacies and grocery stores. Dietary supplements, such as Hydroxycut, do not require FDA approval before they are marketed and are not monitored as closely as prescription medications.
Find the list of recalled products.
If you or someone you love has been using Hydroxcut products or experienced any of the injuries or symptoms described above, please contact Seeger Weiss LLP's experienced staff to discuss your potential claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, and Pennsylvania and its attorneys practice in courts throughout the country.
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- Sleeping Pill Dangers
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
Pending Settlements
